Gimv NV

  • Market Cap: N/A
  • Industry: Capital Markets
  • ISIN: BE0003699130
EUR
44.00
-1.68 (-3.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Gimv NV stock-summary
stock-summary
Gimv NV
Capital Markets
Gimv Investeringsmaatschappij Voor Vlanderen NV, formerly Gimv NV, is a Belgium-based investment provider of private equity and venture capital. In the Buyouts & Growth segment, the Company has four business units in Belgium, the Netherlands, Germany and France. The Technology, Life Sciences and Cleantech trends business units together form the Venture Capital segment. The Funds & Joint Ventures segment is formed by Gimv-XL, Gimv-Agri+, Central Europe & Russia, DG Infra+ and other funds. Through EcoChem International, it invests in innovation, product development, manufacturing and distribution of eco-friendly flame retardant additives. Through the DG Infra+ fund the Company invests companies, projects and infrastructure related assets in sectors, such as transport and logistics infrastructure, utilities, social and healthcare infrastructure, and communication networks. It operates through Summa, France Thermes, Acceo, AgroBiothers, IMPACT, Rovipharm and Nova Engineering.
Company Coordinates stock-summary
Company Details
Karel Oomsstraat 37 , ANTWERPEN None : 2018
stock-summary
Tel: 32 3 290210032 03 2902290
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mrs. Hilde Laga
Non-Executive Chairman of the Board
Mr. Koen Dejonckheere
Chief Executive Officer, Executive Director
Ms. Brigitte Boone
Non-Executive Director
Mr. Marc Descheemaecker
Non-Executive Director
Mr. Geert Peeters
Non-Executive Director
Mr. Karel Plasman
Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
157 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summary
Industry

Capital Markets

stock-summary
Market cap

EUR 1,612 Million ()

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

11.04%

stock-summary
Price to Book

0.81